TOMSICEK MICHAEL JOHN 4
4 · Milestone Pharmaceuticals Inc. · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
Milestone (MIST) Director Michael Tomsicek Receives 77,000-Share Award
What Happened
Michael Tomsicek, a director of Milestone Pharmaceuticals, received a derivative award on 2026-06-10 covering 77,000 shares. The Form 4 reports the award at $0.00 (aggregate $0) — this is a grant/award (derivative), not an open-market purchase or sale.
Key Details
- Transaction date: 2026-06-10; filing date: 2026-06-12 (filed promptly after the reported transaction).
- Transaction type/code: Grant/Award (A) of a derivative covering 77,000 shares; reported price $0.00 (aggregate $0).
- Shares owned after transaction: Not specified in the provided filing summary.
- Footnote: The option vests in twelve equal monthly installments beginning July 10, 2026; it will fully vest on the date of the next annual meeting if the reporting person remains in service.
- No 10b5-1, tax-withholding, or sale noted in this filing.
Context
This was an equity award to a director (common as part of board compensation), not a cash purchase or sale of stock. Because it’s a derivative grant with a time-based vesting schedule, the shares are not immediately owned outright and will only become exercisable/vest over the stated schedule (or at next annual meeting per the footnote) subject to continued service.
Insider Transaction Report
- Award
Stock Option (right to buy)
[F1]2026-06-10+77,000→ 77,000 totalExercise: $1.22Exp: 2036-06-10→ Common Stock (77,000 underlying)
Footnotes (1)
- [F1]This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2026, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date.